Viracta Therapeutics Statistics

Total Valuation

VIRX has a market cap or net worth of $5.88 million. The enterprise value is $253,468.

Market Cap	5.88M
Enterprise Value	253,468

Important Dates

The last earnings date was Wednesday, November 13, 2024, before market open.

Earnings Date	Nov 13, 2024
Ex-Dividend Date	n/a

Share Statistics

VIRX has 39.42 million shares outstanding. The number of shares has increased by 1.99% in one year.

Current Share Class	39.42M
Shares Outstanding	39.42M
Shares Change (YoY)	+1.99%
Shares Change (QoQ)	+0.43%
Owned by Insiders (%)	2.69%
Owned by Institutions (%)	14.95%
Float	28.40M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	7.05
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-12.75

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Capital (ROIC)	-76.59%
Revenue Per Employee	n/a
Profits Per Employee	-$1.08M
Employee Count	40
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -72.69% in the last 52 weeks. The beta is 0.30, so VIRX's price volatility has been lower than the market average.

Beta (5Y)	0.30
52-Week Price Change	-72.69%
50-Day Moving Average	0.21
200-Day Moving Average	0.55
Relative Strength Index (RSI)	24.48
Average Volume (20 Days)	2,679,824

Short Selling Information

The latest short interest is 2.69 million, so 6.83% of the outstanding shares have been sold short.

Short Interest	2.69M
Short Previous Month	1.10M
Short % of Shares Out	6.83%
Short % of Float	9.48%
Short Ratio (days to cover)	1.85

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-47.21M
Pretax Income	-47.99M
Net Income	-43.29M
EBITDA	-46.80M
EBIT	-47.21M
Earnings Per Share (EPS)	-$1.10

Full Income Statement

Balance Sheet

The company has $30.01 million in cash and $18.82 million in debt, giving a net cash position of $11.19 million or $0.28 per share.

Cash & Cash Equivalents	30.01M
Total Debt	18.82M
Net Cash	11.19M
Net Cash Per Share	$0.28
Equity (Book Value)	2.67M
Book Value Per Share	-0.07
Working Capital	n/a

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

VIRX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.99%
Shareholder Yield	-1.99%
Earnings Yield	-709.91%
FCF Yield	n/a

Analyst Forecast

The average price target for VIRX is $5.00, which is 3,253.45% higher than the current price. The consensus rating is "Buy".

Price Target	$5.00
Price Target Difference	3,253.45%
Analyst Consensus	Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-31.89%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a